Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina

E Marc Jolicœur1, Matthieu Pelletier-Galarneau2

  • 1Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.

Insights

Diagnosing vasospastic angina can be challenging. Rubidium-82 positron emission tomography myocardial perfusion imaging (82Rb PET-MPI) with ergonovine effectively identified spasm in a complex patient case.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Diagnostic Imaging

Background:

  • Intracoronary reactivity testing is the gold standard for diagnosing vasospastic angina but is invasive and limited to specialized centers.
  • Current noninvasive methods like SPECT and echocardiography lack precision in localizing coronary artery spasm and quantifying its impact on myocardial perfusion.

Observation:

  • A patient with refractory vasospastic angina, complex ischemic syndrome, recent coronary stenting, and persistent atypical angina despite optimal medical therapy was evaluated.
  • Rubidium-82 positron emission tomography myocardial perfusion imaging (82Rb PET-MPI) was utilized in conjunction with intravenous ergonovine administration.

Findings:

  • 82Rb PET-MPI successfully diagnosed vasospastic angina in this complex patient scenario, demonstrating its utility in challenging cases.
  • The imaging technique allowed for the localization of coronary artery spasm and assessment of its functional significance.

Implications:

  • 82Rb PET-MPI offers a promising noninvasive alternative for diagnosing vasospastic angina, particularly in patients with refractory symptoms or complex cardiac conditions.
  • This advanced imaging modality could improve diagnostic accuracy and guide treatment strategies for vasospastic angina, potentially expanding its use beyond specialized centers.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
242
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
309
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
79
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
76
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
895